A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HBsAb / hepatitis B surface antibody

[Related PubMed/MEDLINE]
Total Number of Papers: 144
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HBsAb  (>> Co-occurring Abbreviation)
Long Form:   hepatitis B surface antibody
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Changes in hepatitis B antibody status after chemotherapy in children with acute lymphoblastic leukemia. ALL, HBV
2019 Hepatitis B vaccination coverage among medical residents from Catania University Hospital, Italy. HBcAb, HBV, HCWs, HIV-Ab, MRs
2019 Immunisation after hepatitis B polyvalent vaccination among children in South Kivu Province, Democratic Republic of the Congo. DRC, HBV
2019 Improved Antibody Response to Three Additional Hepatitis B Vaccine Doses Following Primary Vaccination Failure in Patients with Inflammatory Bowel Disease. CD, IBD, UC
2019 Predictors of sustained functional cure in hepatitis B envelope antigen-negative patients achieving hepatitis B surface antigen seroclearance with interferon-alpha-based therapy. CHB, CI, HBeAg, HBsAg, HBV, OR
2019 Reactivation of Hepatitis B Virus Infection With Reverse Seroconversion Following Umbilical Cord Allogeneic Hematopoietic Cell Transplantation in a Hepatitis-B-Immune Patient: A Case Report. HBsAg, HBV, UHCT
2019 Serological Changes against Hepatitis B Surface Antigen in Children and Adolescents Receiving Chemotherapy for Acute Leukemia. HBV
2018 Durability of the hepatitis B vaccination in pediatric renal transplant recipients. HBV
2018 Effect of antiviral therapy in reducing perinatal transmission of hepatitis B virus and maternal outcomes after discontinuing them. HBV, MTCT
10  2018 Hepatitis B Virus Vaccination in HIV: Immunogenicity and Persistence of Seroprotection up to 7 Years Following a Primary Immunization Course. CI, HBV, PLHIV
11  2018 Immunoreaction-Mediated Aggregation of Gold Nanoparticles for Sensitive and Selective Assay of Hepatitis B Surface Antigen. HBsAg, TNB
12  2018 MiR-18a and miR-17 are positively correlated with circulating PD-1+ICOS+ follicular helper T cells after hepatitis B vaccination in a chinese population. cTfh, HBV
13  2018 Misleading hepatitis B serology following Rho (D) immune globulin (human) injection and influenza vaccine. HBcAb
14  2018 Use of ELISpot assay to study HBs-specific B cell responses in vaccinated and HBV infected humans. CHB, ELISPOT, HBs, HBV
15  2017 A Multicenter Phase III Study to Evaluate the Efficacy and Safety of Hepabulin, a New Hepatitis B Immunoglobulin, in Liver Transplantation Recipients with Hepatitis B. AEs, HBeAg, HBIG, HBsAg, HBV
16  2017 Assessment of hepatitis B virus antibody titers in childhood cancer survivors. HBV
17  2017 Changes in hepatitis B virus antibody titers over time among children: a single center study from 2012 to 2015 in an urban of South Korea. HBV
18  2017 Evaluation of Response to Hepatitis B Vaccination in Chronic Hemodialysis Patients. HBV, HD
19  2017 Factors Affecting the Development of an Antibody Response to Hepatitis B Immunization in Children With Intestinal Failure: Before and After Small Bowel Transplantation (With and Without Liver Graft). HBV
20  2017 Hepatitis B virus infection in an HBsAb-positive lymphoma patient who received chemotherapy: A case report. HBV
21  2017 Immunity against vaccine-preventable diseases in Finnish pediatric healthcare workers in 2015. HCWs
22  2017 Immunogenicity of Augmented Compared With Standard Dose Hepatitis B Vaccine in Pediatric Patients on Dialysis: a Midwest Pediatric Nephrology Consortium Study. ---
23  2017 Incidence of Low Seroimmunity to Hepatitis B Virus in Children With Inflammatory Bowel Disease. IBD
24  2017 Long-term safety and efficacy of telbivudine in infants born to mothers treated during the second or third trimesters of pregnancy. HBV
25  2017 Polydiacetylene/Anti-HBs Complexes for Visible and Fluorescent Detection of Hepatitis B Surface Antigen on a Nitrocellulose Membrane. HBsAg, ICA, NC, PDA
26  2017 Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women. HBcAb, HBV
27  2017 The Effect of Oral Levamisole Co-administration on the Level of Immune Response to Hepatitis B Vaccine in Healthy Individuals: A Randomized Clinical Trial. ---
28  2017 [Application of active immunization in the prevention of de novo hepatitis B virus infection after pediatric liver transplantation with HBcAb positive donor liver]. HBcAb, HBIG, HBV
29  2016 De novo hepatitis b prophylaxis with hepatitis B virus vaccine and hepatitis B immunoglobulin in pediatric recipients of core antibody-positive livers. DNHB, HBIG, HBV, LT
30  2016 Does the antibody production ability affect the serum anti-Helicobacter pylori IgG titer? H. pylori, HBsAg, IgG, PG
31  2016 Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review-Screened. HBeAg, HBsAg, HBV, HBVr, TNF-alpha
32  2016 Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical Trial. HBV, HIV-1
33  2016 One-year extended, monthly vaccination prophylaxis combined with hepatitis B immune globulin for hepatitis B after liver transplantation. HBIG, HBV
34  2016 Positive hepatitis B surface antibody is associated with reduced risk of diabetes mellitus in retired female Chinese workers. OGTT, T2D
35  2016 Prevalence and characterization of occult hepatitis B infection among blood donors in central Saudi Arabia. HBcAb, HBsAg, HBV, OBIs
36  2015 De novo hepatitis B virus infection developing after liver transplantation using a graft positive for hepatitis B core antibody. HBcAb
37  2015 Decreased blood hepatitis B surface antibody levels linked to e-waste lead exposure in preschool children. e-waste, GLMMs
38  2015 Effect of tetanus-diphtheria (Td) vaccine on immune response to hepatitis B vaccine in healthy individuals with insufficient immune response. HBV, Iran, Td
39  2015 Efficacy and long-term durability of intradermal recombinant hepatitis B virus vaccine among intramuscular vaccine nonresponders: A prospective study in healthcare personnel. HBV
40  2015 Hepatitis B Virus Infection Rate and Distribution in Chinese Systemic Lupus Erythematosus Patients. HBcAb, HBV, SLE
41  2015 Hepatitis B Virus Revaccination With Standard Versus Pre-S Vaccine in Previously Immunized Patients With Celiac Disease. CD, HBV, IQR
42  2015 Immunogenicity of Recombinant Hepatitis B Vaccine Among Routinely Vaccinated Healthy and Chronically Ill Children in Assiut, Upper Egypt. ELISA, HB, HBV
43  2015 Outcomes of the implementation of the computer-assisted HBView system for the prevention of hepatitis B virus reactivation in chemotherapy patients: a retrospective analysis. HBcAb, HBsAg, HBV
44  2015 Protective immune barrier against hepatitis B is needed in individuals born before infant HBV vaccination program in China. HBsAg
45  2015 The prevalence of isolated hepatitis B core antibody and its related risk factors among male injected drug users in Isfahan prisons. HBsAg, HBV, IDU
46  2015 The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy. DLBCL, HBcAb, HBsAg, HBV, HBV, IPI
47  2015 Using Clinical Databases to Verify the Impact of Regulatory Agency Alerts in Japan: Hepatitis B Testing Behavior After an Alert Regarding Risk of Viral Reactivation. HBcAb, HBsAg, HBV-DNA, PMDA
48  2015 [IL-35 level of peripheral blood is correlated with the immune response to hepatitis B vaccine]. EBV, PBMCs
49  2014 A proposal for management of rheumatic disease patients with hepatitis B virus infection receiving immunosuppressive therapy. HBcAb, HBsAg, HBV
50  2014 Applicability and efficacy of a model for prevention of perinatal transmission of hepatitis B virus infection: single center study in Egypt. HBsAg, HBV
51  2014 Efficacy of double dose recombinant hepatitis B vaccination in chronic hepatitis C patients, compared to standard dose vaccination. HBV, HCV
52  2014 Factors affecting response to hepatitis B vaccine among hemodialysis patients in a large Saudi Hemodialysis Center. BMI, HBV, HCV, HD, PCR, PSCKD, SGA, URR
53  2014 Frequent incidence of escape mutants after successful hepatitis B vaccine response and stopping of nucleos(t)ide analogues in liver transplant recipients. HB, HBV, LT, NAs
54  2014 Guillain-Barre syndrome associated with Japanese encephalitis virus infection in China. GBS, JEV
55  2014 Hepatitis B virus (HBV) reverse seroconversion (RS) can be prevented even in non-responders to hepatitis B vaccine after allogeneic stem cell transplantation: long-term analysis of intervention in RS with vaccine for patients with previous HBV infection. HBV, RS
56  2014 Hepatitis C and hepatitis B virus infections in the etiopathogenesis of pemphigus. HBsAg
57  2014 Liver and renal safety of tenofovir disoproxil fumarate in combination with emtricitabine among African women in a pre-exposure prophylaxis trial. TDF-FTC
58  2014 Prevalence of hepatitis B virus infection in patients with rheumatic diseases in Tohoku area: a retrospective multicenter survey. HBcAb, HBsAg, HBV, RA, SLE
59  2014 Risk factors for de novo hepatitis B infection in pediatric living donor liver transplantation. HBcAb, HBV, LDLT
60  2014 [Construction and application of plasmid pVAX-HBVE harboring hepatitis B surface antibody targeted interferon and interleukin 12 genes]. hIL-12
61  2014 [Fulminant hepatic failure and hepatitis B virus reactivation: case reports and analyses of the pathological mechanism]. FHF, HBeAg, HBV
62  2013 Adefovir is effective to promote development of immunity to donor origin hepatitis B virus in an allogeneic transplant recipient: a case report. HBcAb, HBeAb, HBsAg, HBV, HCT
63  2013 Changing trends of hepatitis B seromarkers amongst Pakistani population: a laboratory-based review. HBsAg
64  2013 Cyclosporine combined with nonlytic interleukin 2/Fc fusion protein improves immune response to hepatitis B vaccination in a mouse skin transplantation model. Fc, IL
65  2013 Field tested milliliter-scale blood filtration device for point-of-care applications. ALT, AST, HBeAb, HBeAg
66  2013 Hepatitis B in immunosuppressed cancer patients: pathogenesis, incidence and prophylaxis. HBsAg, HBV
67  2013 NIR-emitting quantum dot-encoded microbeads through membrane emulsification for multiplexed immunoassays. HBcAb, HBeAb, HBeAg, HBsAg, HBV, PSMA, SPG
68  2013 Outcomes and risk factors for hepatitis B virus (HBV) reactivation after kidney transplantation in occult HBV carriers. HBcAb, HBsAg, HBV
69  2013 Role of T follicular helper cells and their associated molecules in the pathogenesis of chronic hepatitis B virus infection. CD40L, ELISA, HBeAg, HBsAg, HBV, IL, Tfh
70  2013 Seroprevalence of hepatitis B virus and human immunodeficiency virus among young prisoners. HBcAb, HBsAg, HBV, HIV
71  2013 [A case of hepatitis B virus reactivation in a patient with prior resolved hepatitis B infection during bevacizumab plus FOLFIRI treatment]. HBcAb, HBeAb, HBeAg, HBsAg, HBV
72  2012 Detection of hepatitis B surface antigen by target-induced aggregation monitored by dynamic light scattering. GNPs, HBsAg, LOD, TEM
73  2012 Effects of Oral Levamisole as an Adjuvant to Hepatitis B Vaccine in HIV/ AIDS Patients: A Randomized Controlled Trial. HBV, HIV
74  2012 Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy. HBsAg, HBV
75  2012 Renal grafts from anti-hepatitis B core-positive donors: a quantitative review of the literature. CI, ESRD, HBcAb, HBsAg, HBV
76  2012 The recombinant hepatitis B surface antigen vaccine in persons with HIV: is seroconversion sufficient for long-term protection? HIV
77  2012 [Analysis of hepatitis B surface antibody in 3022 children]. ---
78  2011 Efficacy of HBV vaccination in various stages of chronic kidney disease: is earlier better? CKD, eGFR, ESRD, HD
79  2011 Long-term results of hepatitis B immunoglobulin and lamuvidine for hepatitis B prophylaxis after liver transplantation. ---
80  2011 Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis. DNH, HBcAb, HBsAg, OR
81  2010 Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer. aa, CT, HBsAg, HBV-R, HSCT
82  2010 Gold nanorod-based localized surface plasmon resonance biosensor for sensitive detection of hepatitis B virus in buffer, blood serum and plasma. DLS, GNRs, HBsAg, HBV, LSPR
83  2010 Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis. HBIG, HBsAg, HBV, MTCT, OR, RCTs
84  2010 Hepatitis B surface antigenemia following recombinant Engerix B hepatitis B vaccine in an 81-year-old ESRD patient on hemodialysis. HB DNA, HB E Ag, HBsAg, HBV, HD
85  2010 Persistence of HBV Vaccine's Protection and Response to Hepatitis B Booster Immunization in 5- to 7-Year-Old Children in the Kohgiloyeh and Boyerahmad Province, Iran. anti-HBs, ELISA, HBsAg, HBV
86  2010 [Prevention of hepatitis B virus reactivation in B-cell lymphoma patients receiving chemotherapy with rituximab]. HBcAb, HBsAg, HBV
87  2009 A label-free amperometric immunosensor based on biocompatible conductive redox chitosan-ferrocene/gold nanoparticles matrix. CS-Fc, HBsAg
88  2009 Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect). HBcAb, HBsAg, HBV, ST, TI, TM, TTI
89  2009 Development of up-converting phosphor technology-based lateral-flow assay for rapidly quantitative detection of hepatitis B surface antibody. UPT-LF
90  2009 Double-dose double-phase use of second generation hepatitis B virus vaccine in patients after living donor liver transplantation: Not an effective measure in transplant recipients. HBcAb, HBIG, HBV, LT
91  2009 Enhancement of sensitivity and specificity of the fluoroimmunoassay of Hepatitis B virus surface antigen through "flexible" coupling between quantum dots and antibody. Ab, AFM, PG, QDs
92  2009 Production of surface plasmon resonance based assay kit for hepatitis diagnosis. AFM, PHEMAT, SPR
93  2009 Surface acoustic wave immunosensor for real-time detection of hepatitis B surface antibodies in whole blood samples. BSA, HBsAg, SAW
94  2008 Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patients. HBcAb, HBV
95  2008 Fabrication, characterization, and application of potentiometric immunosensor based on biocompatible and controllable three-dimensional porous chitosan membranes. HBsAg
96  2008 Markers for hepatitis A, B and C in methadone maintained patients: an unexpectedly high co-infection with silent hepatitis B. HBcAb, HBsAg, IgG, IgM
97  2008 Simultaneous expression of growth hormone releasing hormone (GHRH) and hepatitis B surface antigen/somatostatin (HBsAg/SS) fusion genes in a construct in the skeletal muscle enhances rabbit weight gain. CHO, GH, GHRH, HBsAg, IGF-I, PLGA, RT-PCR, SS
98  2007 Association between hepatitis B surface antibody seropositivity and coronary artery disease. CAD, ELISA, HBV
99  2007 Evaluation of immune response to Hepatitis B vaccine in health care workers at a tertiary care hospital in Pakistan: an observational prospective study. HBV, HCWs
100  2007 HBV vaccination in hyperendemic remote tribal areas in India. ---